Vigabatrin improves paroxysmal dystonia in succinic semialdehyde dehydrogenase deficiency

Neurology

Volumn 68, Issue 16, 2007, Pages 1320-1321

  Leuzzi, V ^a   Di Sabato, M L ^a   Deodato, F ^b   Rizzo, C ^b   Boenzi, S ^b   Carducci, C ^a   Malaspina, P ^c   Liberanome, C ^a   Dionisi Vici, C ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SERTRALINE; SUCCINATE SEMIALDEHYDE DEHYDROGENASE; VIGABATRIN;

ADOLESCENT; ADULT; ARTICLE; AUTISM; CASE REPORT; DYSTONIA; ENZYME DEFICIENCY; GENERALIZED EPILEPSY; HUMAN; LANGUAGE DISABILITY; MALE; MENTAL DEFICIENCY; MOTOR DYSFUNCTION; OBSESSIVE COMPULSIVE DISORDER; PAROXYSMAL DYSTONIA; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; SEIZURE;

ADOLESCENT; BRAIN; BRAIN DISEASES, METABOLIC; DYSTONIC DISORDERS; EPILEPSY; EXTREMITIES; GABA AGENTS; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; HYDROXYBUTYRATES; ITALY; MALE; MENTAL RETARDATION; MUSCLE, SKELETAL; MUTATION, MISSENSE; SUCCINATE-SEMIALDEHYDE DEHYDROGENASE; TREATMENT OUTCOME; VIGABATRIN;

EID: 34247245326     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000259537.54082.6d     Document Type: Article

References (7)

1. Gibson KM, Christensen E, Jakobs C, et al. The clinical phenotype of SSADH deficiency: case reports of 23 new patients. Pediatrics 1997;99:567-574.
2. Pearl PL, Capp PK, Novotny EJ, Gibson KM. Inherited disorders of neurotransmitters in children and adults. Clin Biochem 2005;38:1051-1058.
3. Rahbeeni A, Ozand PT, Rashed M, et al. 4-Hydroxybutiric aciduria. Brain Dev 1994;16:S64-S71.
4. De Biase D, Barra D, Bossa F, Pucci P, John RA. Chemisry of the inactivation of 4-aminobutyrate aminotransferase by the antiepileptic drug vigabatrin. J Biol Chem 1991;266:20054-20061.
5. Ergezinger K, Jeschke R, Frauendiest-Egger G, Korall H, Gibson KM, Schuster VH. Monitoring of 4-hydroxybutyric acid levels in body fluids during vigabatrin treatment in succinic semialdehyde dehydrogenase deficiency. Ann Neurol 2003;54:686-689.
6. Jansen EEW, Verhoeven NM, Jakobs C, et al. Increased guanidine species in murine and human succinate semialdehyde dehydrogenase (SSADH) deficiency. Biochim Biophys Acta 2006;1762:494-498.
7. Mercimek-Mahmutoglu S, Stoeckler-Ipsiroglu S, Adami A, et al. GAMT deficiency: features, treatment, and outcome in an inborn error of creatine synthesis. Neurology 2006;67:480-484.